Canton Hathaway’s Biohaven BHVN Stock Holding History

Canton Hathaway’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$300K	Sell	22,500 -100	-0.4%	-$1.45K	0.06%	107
2026 Q2	$336K	Buy	22,600 +100	+0.4%	+$1.08K	0.06%	102
2026 Q1	$190K	Hold	22,500	–	–	0.04%	131
2025 Q4	$254K	Sell	22,500 -3,900	-15%	-$48.3K	0.05%	122
2025 Q3	$396K	Sell	26,400 -4,100	-13%	-$59.7K	0.08%	112
2025 Q2	$430K	Buy	30,500 +9,150	+43%	+$163K	0.09%	104
2025 Q1	$513K	Hold	21,350	–	–	0.1%	81
2024 Q4	$797K	Hold	21,350	–	–	0.2%	51
2024 Q3	$1.07M	Sell	21,350 -500	-2%	-$19.5K	0.27%	44
2024 Q2	$758K	Buy	21,850 +500	+2%	+$19.8K	0.21%	51
2024 Q1	$1.17M	Hold	21,350	–	–	0.31%	39
2023 Q4	$914K	Sell	21,350 -500	-2%	-$15.6K	0.28%	41
2023 Q3	$568K	Buy	21,850 +500	+2%	+$10.4K	0.18%	49
2023 Q2	$511K	Sell	21,350 -1,300	-6%	-$22.4K	0.16%	56
2023 Q1	$309K	Buy	22,650 +5,050	+29%	+$80.4K	0.11%	68
2022 Q4	$244K	Buy	17,600 +13,508	+330%	+$191K	0.08%	82
2022 Q3	$605K	Buy	+4,092	New	+$29.7K	0.22%	54

Other funds holding BHVN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

QTR Family Wealth Lake Mary, Florida $270M AUM 34.3% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Canton Hathaway's BHVN Position: Q3 2026 in Review

Canton Hathaway reduced its Biohaven (BHVN) stake by 0.44% in Q3 2026, selling an estimated $1.45K and leaving 22,500 shares worth $300K. The position accounts for 0.06% of the portfolio, ranked #107.

Canton Hathaway first reported a position in BHVN in Q3 2022 and has held it in 17 quarters since. The position peaked at $1.17M in Q1 2024. 108 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

Canton Hathaway held 22,500 shares of Biohaven worth $300K as of Q3 2026.
Canton Hathaway sold 100 Biohaven shares in Q3 2026, an estimated $1.45K.
Biohaven made up 0.06% of Canton Hathaway's portfolio in Q3 2026, its #107 holding.
Canton Hathaway first reported a position in Biohaven in Q3 2022 and has held it in 17 quarters since.
Canton Hathaway's Biohaven position peaked at $1.17M in Q1 2024.
108 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Canton Hathaway's 13F filing for Q3 2026, filed 23 Oct 2026.